European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

SSRN Electronic Journal
doi 10.2139/ssrn.932989
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Pharmaceutical Price Regulation Scheme

BMJ
2007English

Late-Stage Pharmaceutical R&D and Pricing Policies Under Two-Stage Regulation

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

Recession Causes Fall in R&D Spending

Nature
Multidisciplinary
1993English

Figures Confirm Global R&D Spending Trends

Nature
Multidisciplinary
1995English

Corporate R&D and Firm Efficiency: Evidence From Europe’s Top R&D Investors

Journal of Productivity Analysis
EconometricsEconomicsInternational ManagementBusinessSocial Sciences
2011English

Diagnosing Inter Firm Profitability of Pharmaceutical Industry: An Empirical Analysis for India

International Journal of Current Research and Review
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2017English

Innovation Culture, R&D Intensity, and Firm Innovation

2020English

Firm Employment Growth, R&D Expenditures and Exports

SSRN Electronic Journal
2015English

Endogenous Firm Heterogeneity, ICT and R&D Incentives

SSRN Electronic Journal
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy